Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma

Pathology Research and Practice

Volumn 209, Issue 4, 2013, Pages 221-227

  Niu, Yun ^a,b   Wang, Shuling ^b   Liu, Tieju ^b   Zhang, Tongwen ^c   Wei, Xiyin ^b   Wang, Ying ^c   Jiang, Linghuo ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

Breast cancer; Centrosome; DNA ploidy; Premalignant lesions; Tubulin

Indexed keywords

ALPHA TUBULIN; GAMMA TUBULIN; TUBULIN;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CENTROSOME; CONTROLLED STUDY; DIPLOIDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PLOIDY; PRECANCER; PROTEIN EXPRESSION;

ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CENTROSOME; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERPLASIA; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PLOIDIES; PRECANCEROUS CONDITIONS; TUBULIN;

EID: 84876329012     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.12.006     Document Type: Article

References (35)

1. Althuis M.D., Dozier J.M., Anderson W.F., et al. Global trends in breast cancer incidence and mortality 1973-1997. Int. J. Epidemiol. 2005, 34:405-412.
2. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J. Clin. 2011, 61:409-418.
3. Page DL Breast lesions, pathology and cancer risk. Breast J. 2004, 10(Suppl. (1)):S3-S4.
4. Costa A. Precancerous lesions of the breast. Ann. Oncol. 2006, 17(Suppl. (10)):x271-x273.
5. Arpino G., Laucirica R., Elledge R.M. Premalignant and in situ breast disease: biology and clinical implications. Ann. Intern. Med. 2005, 143:446-457.
6. Pinder S.E., Ellis I.O. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) - current definitions and classification. Breast Cancer Res. 2003, 5:254-257.
7. Lange B.M. Integration of the centrosome in cell cycle control, stress response and signal transduction pathways. Curr. Opin. Cell Biol. 2002, 14:35-43.
8. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2002, 2:815-825.
9. Adeyinka A., Baldetorp B., Mertens F., et al. Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas. Cancer Genet. Cytogenet. 2003, 147:62-67.
10. Geigl J.B., Obenauf A.C., Schwarzbraun T., Speicher M.R. Defining 'chromosomal instability'. Trends Genet. 2008, 24:64-69.
11. Inaba S., Li C., Shi Y.E., et al. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res. Treat. 2005, 94:25-35.
12. Salisbury J.L., D'Assoro A.B., Lingle W.L. Centrosome amplification and the origin of chromosomal instability in breast cancer. J. Mammary Gland Biol. Neoplasia 2004, 9:275-283.
13. Pihan G.A., Wallace J., Zhou Y., Doxsey S.J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003, 63:1398-1404.
14. Plouffe D.A., Belosevic M. Antibodies that recognize alpha- and beta-tubulin inhibit in vitro growth of the fish parasite Trypanosoma danilewskyi, Laveran and Mesnil, 1904. Dev. Comp. Immunol. 2006, 30:685-697.
15. Raynaud-Messina B., Merdes A. Gamma-tubulin complexes and microtubule organization. Curr. Opin. Cell Biol. 2007, 19:24-30.
16. Tavassoli F.A., Devilee P. The WHO Classification of Tumors of the Breast and Female Genital Organs 2003, IARC Press, Lyon.
17. Delattre M., Gonczy P. The arithmetic of centrosome biogenesis. J. Cell Sci. 2004, 117:1619-1630.
18. Sankaran S., Parvin J.D. Centrosome function in normal and tumor cells. J. Cell. Biochem. 2006, 99:1240-1250.
19. Doxsey S., Zimmerman W., Mikule K. Centrosome control of the cell cycle. Trends Cell Biol. 2005, 15:303-311.
20. Nigg E.A. Centrosome duplication: of rules and licenses. Trends Cell Biol. 2007, 17:215-221.
21. Duensing A., Liu Y., Tseng M., et al. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 2006, 25:2943-2949.
22. Muto Y., Yoshioka T., Kimura M., et al. An evolutionarily conserved leucine-rich repeat protein CLERC is a centrosomal protein required for spindle pole integrity. Cell Cycle 2008, 7:2738-2748.
23. Bornens M. Centrosome composition and microtubule anchoring mechanisms. Curr. Opin. Cell Biol. 2002, 14:25-34.
24. Salisbury J.L. The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer. J. Mammary Gland Biol. Neoplasia 2001, 6:203-212.
25. Kubo A., Tsukita S. Non-membranous granular organelle consisting of PCM-1: subcellular distribution and cell-cycle-dependent assembly/disassembly. J. Cell Sci. 2003, 116:919-928.
26. Fukasawa K. Introduction. Centrosome. Oncogene 2002, 21:6140-6145.
27. Schnerch D., Hasskarl J., Engelhardt M., Wasch R. Origin and role of aneuploidy in cancer. Dtsch. Med. Wochenschr. 2006, 131:1747-1753.
28. Bharadwaj R., Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene 2004, 23:2016-2027.
29. Chi Y.H., Jeang K.T. Aneuploidy and cancer. J. Cell. Biochem. 2007, 102:531-538.
30. Pellman D. Cell biology: aneuploidy and cancer. Nature 2007, 446:38-39.
31. Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 2005, 230:6-19.
32. Basto R., Pines J. The centrosome opens the way to mitosis. Dev. Cell 2007, 12:475-477.
33. Niu Y., Wang Y., Yu Y., et al. Expression of alpha-tubulin and gamma-tubulin in premalignant lesion and carcinoma of breast and the significance thereof. Zhonghua Yi Xue Za Zhi 2006, 86:56-60.
34. Niu Y., Wang Y., Wei L., et al. A quantitative immuno-fluorescence analysis of alpha-tubulin and gamma-tubulin proteins in precancerous lesion and carcinoma of the breast and their clinical significance. Zhonghua Zhong Liu Za Zhi 2006, 28:590-593.
35. Niu Y., Liu T., Tse G.M., et al. Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast. Cancer Sci. 2009, 100:580-587.